Antisense Technology: An Emerging Platform for Cardiovascular Disease Therapeutics

Antisense oligonucleotides and small interfering RNAs, which suppress the translation of specific mRNA target proteins, are emerging as important therapeutic modalities for the treatment of cardiovascular disease. Over the last 25 years, the advances in all aspects of antisense technology, as well a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Richard G., Crosby, Jeff, Baker, Brenda F., Graham, Mark J., Crooke, Rosanne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838598/
https://www.ncbi.nlm.nih.gov/pubmed/23856914
http://dx.doi.org/10.1007/s12265-013-9495-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838598/
https://www.ncbi.nlm.nih.gov/pubmed/23856914
http://dx.doi.org/10.1007/s12265-013-9495-7

Ejemplares similares